IGF2BP3 has been characterized as an oncoprotein and a useful biomarker for a variety of cancers, including adenocarcinoma (34), intrahepatic cholangiocarcinoma (35), squamous esophageal cancer (36), and colon cancer (37). Here, IGF2BP3 is linked to cancer.